Health in Tech Inc.

11/13/2026 | Press release | Distributed by Public on 11/13/2026 16:35

Statement of Changes in Beneficial Ownership (Form 4)

FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden hours per response... 0.5
(Print or Type Responses)
1. Name and Address of Reporting Person *
Qian LinLin
2. Issuer Name and Ticker or Trading Symbol
Health In Tech, Inc. [HIT]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director __X__ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Chief Financial Officer
(Last) (First) (Middle)
701 S. COLORADO AVE, SUITE 1
3. Date of Earliest Transaction (Month/Day/Year)
11/10/2026
(Street)
STUART, FL 34994
4. If Amendment, Date Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 11/10/2026 A 650,000(1) A $ 0 9,567,151 D
Class A Common Stock 11/10/2026 A 800,000(2) A $ 0 10,367,151 D
Class A Common Stock 11/10/2026 A 600,000(3) A $ 0 10,967,151 D
Class A Common Stock 11/10/2026 A 600,000(4) A $ 0 11,567,151 D
Class A Common Stock 11/10/2026 A 200,000(5) A $ 0 11,767,151 D
Class A Common Stock 11/10/2026 A 200,000(6) A $ 0 11,967,151(8) D
Class B Common Stock 11/10/2026 A 200,000(7) A $ 0 2,900,000(9) D
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(Month/Day/Year)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Qian LinLin
701 S. COLORADO AVE, SUITE 1
STUART, FL 34994
X X Chief Financial Officer

Signatures

/s/ Lori Babcock, as attorney-in-fact for LinLin Qian 11/13/2026
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Represents restricted shares of Class A Common Stock granted under the Health In Tech, Inc. Equity Incentive Plan (the "Plan") pursuant to a Restricted Stock Award Agreement dated as of October 20, 2026. The grant was contingent upon, and the shares were issued upon, stockholder approval of an amendment to the Plan at the Issuer's 2026 Annual Meeting of Stockholders on November 10, 2026. The shares vest in twelve equal monthly installments commencing November 15, 2026, subject to continued service through each vesting date.
(2) Represents restricted shares of Class A Common Stock that vest in full upon the closing of an acquisition by the Issuer on or before December 31, 2028, subject to continued service through such closing, and are otherwise forfeited without consideration.
(3) Represents restricted shares of Class A Common Stock that are forfeited without consideration unless the Issuer's market capitalization (measured by 10-day VWAP) exceeds $150 million on or before April 30, 2028 (the "Achievement Date"). Thereafter, the shares vest in twelve equal monthly installments, subject to continued service, commencing on the 15th of the month if the Achievement Date is before the 15th, or otherwise on the 1st of the next month.
(4) Represents restricted shares of Class A Common Stock that are forfeited without consideration unless the Issuer's market capitalization (measured by 10-day VWAP) exceeds $300 million on or before December 31, 2028 (the "Achievement Date"). Thereafter, the shares vest in twelve equal monthly installments, subject to continued service, commencing on the 15th of the month if the Achievement Date is before the 15th, or otherwise on the 1st of the next month.
(5) Represents restricted shares of Class A Common Stock that are forfeited without consideration unless the Issuer's market capitalization (measured by 10-day VWAP) exceeds $500 million on or before December 31, 2029 (the "Achievement Date"). Thereafter, the shares vest in twelve equal monthly installments, subject to continued service, commencing on the 15th of the month if the Achievement Date is before the 15th, or otherwise on the 1st of the next month.
(6) Represents restricted shares of Class A Common Stock that are forfeited without consideration unless the Issuer's market capitalization (measured by 10-day VWAP) exceeds $1 billion on or before December 31, 2031 (the "Achievement Date"). Thereafter, the shares vest in twelve equal monthly installments, subject to continued service, commencing on the 15th of the month if the Achievement Date is before the 15th, or otherwise on the 1st of the next month.
(7) Represents restricted shares of Class B Common Stock on the terms described in footnote (3).
(8) Includes 3,828,516 restricted shares of Class A Common Stock and 8,138,635 unrestricted shares of Class A Common Stock. Excludes 200,000 restricted shares of Class B Common Stock, 2,700,000 shares of Class B Common Stock and 711,510 options to purchase shares of Class A Common Stock.
(9) All unvested restricted shares reported herein vest in full upon a Change in Control (as defined in the Plan).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.
Health in Tech Inc. published this content on November 13, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on November 13, 2026 at 22:35 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]